| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Metformin Articles
Glumetza
Glumetza, a once-daily extended-release formulation of metformin hydrochloride, was granted FDA approval in June 2005 for the treatment of type 2 diabetes.
According to Biovail, the drug’s manufacturer, Glumetza “may offer potential advantages such as less frequent dosing and proven effectiveness in combination with other diabetes drugs.” In addition, they say that Glumetza offers “excellent tolerability that allows physicians to more quickly administer a high enough dose to provide [blood glucose] control without significantly increasing the incidence of nausea, diarrhea and other side effects that are sometimes caused by metformin products.”
Glumetza is not recommend for people with kidney problems, heart failure that is treated with medicine, or diabetic ketoacidosis. The most common side effects of Glumetza include diarrhea, nausea and upset stomach. Glumetza can also cause lactic acidosis.
Source: Biovail Corp.
Categories: Metformin, Type 2 Issues, Type 2 Medications
Dec 1, 2005 - Not Yet Rated
Email to a Friend
Send a link to this page to your friends and colleagues.